FDA Hits Medline Drug Plant Over 9 Contamination Events
Medline's $6.3B IPO didn't shield it from two FDA warning letters, the second citing nine contamination events at its Illinois plant.
Medline's $6.3B IPO didn't shield it from two FDA warning letters, the second citing nine contamination events at its Illinois plant.
Alphabet priced an $84.75B equity sale on June 2, the largest stock offering in recorded history, with Berkshire Hathaway in for $10B.
The 5th Circuit's May 28 stay put Texas SB 2420 back in force, but four-state ASAA compliance still hinges on a First Amendment ruling.
Louisiana is the 22nd state with a comprehensive privacy law, but CCPA-style thresholds and a narrower sensitive-data scope create compliance gaps.
After three years in the red, Indiana's $116M Farmers and Mechanics Federal Savings Bank now needs FDIC sign-off on every exec hire.
A class action seeks $5M over Ring's Familiar Faces: bystanders scanned without consent can't opt out without tracking down each camera owner.
Trump's AI order cuts pre-release review to 30 days, makes testing voluntary, and lets AI firms decide which of their own models get scrutinized.
Four plaintiffs including AI bias-detection firm SolasAI sued CFPB in D.C. to block the April rule stripping disparate impact from ECOA.
IBI363's phase 1 data put 47% of IO-resistant NSCLC patients alive at 24 months, the first real test of Takeda's $11.4B Innovent bet.
A PAN-OS authentication bypass rated medium on May 13 is now critical and actively exploited, with federal agencies ordered to patch by June 19.
Alphabet's $80B equity raise, anchored by Berkshire's $10B, signals the moment AI capex outpaces Big Tech's collective ability to self-fund.
EU's Cloud and AI Development Act mandates EU-built software in public tenders, a direct shot at Amazon, Google, and Microsoft's state contracts.
Amazon hit £15 billion of a £40 billion UK pledge in year one, ahead of pace, while embedding a new payment into Prime's billing chain.
Illinois legislators delayed the IFPA swipe fee ban a second year in a row, but OCC preemption means the 2027 date may mean little for national banks.
63.6% of AI vendors don't disclose their subprocessors, 145 state laws hit in 2025, and your CEO now faces personal perjury risk by April 2028.